Our findings uncover the IRF7-CXCL10 axis as a pivotal driver of detrimental neuroinflammation in ischemic stroke and establish IRF7 as a potent therapeutic target for neuroprotection.
Lai et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: